Cyclacel Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cyclacel Pharmaceuticals, Inc.
CIK #0001130166
EDGAR Form CIK 2011 - 2024
10-K [0001130166]
10-Q [0001130166]
3 [0001130166]
4 [0001130166]
5 [0001130166]
8-K [0001130166]
D [0001130166]
SC 13D [0001130166]
SC 13G [0001130166]
Form 13D/13G Filer Form 13D/13G Subject Filed
Altium Capital Management LP Cyclacel Pharmaceuticals Inc [2024-01-10]
Lind Global Fund II LP Cyclacel Pharmaceuticals Inc [2024-01-04]
Schonfeld Strategic Advisors LLC Cyclacel Pharmaceuticals Inc [2023-02-14]
Dellora Investments LP Cyclacel Pharmaceuticals Inc [2022-08-22]
Sphera Funds Management Ltd Cyclacel Pharmaceuticals Inc [2021-03-18]
Acorn BioVentures LP Cyclacel Pharmaceuticals Inc [2021-02-12]
Ikarian Capital LLC Cyclacel Pharmaceuticals Inc [2021-01-11]
Pura Vida Investments LLC Cyclacel Pharmaceuticals Inc [2020-12-28]
Aspire Capital Fund LLC Cyclacel Pharmaceuticals Inc [2020-12-23]
CVI Investments Inc Cyclacel Pharmaceuticals Inc [2020-04-30]
View All
Form 3/4/5 Subject 2011 - 2024
Schwartz Brian
Cyclacel Pharmaceuticals, Inc.
McBarron Paul
Rombotis Spiro George
Spiegel Robert J.
Kirschbaum Mark
Walker Karin L
Ferguson Kenneth M.
Henney Christopher S
Barker Sam L
View All
Terms | Privacy | Guide
tony@aum13f.com